{"schema_version":"1","generated_at":"2026-11-05T03:19:34.427Z","data_as_of":null,"url":"https://www.findmykol.com/kol/mohammad-atiq","json_url":"https://www.findmykol.com/kol/mohammad-atiq/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"mohammad-atiq","name":"Mohammad Atiq","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Chicago","institution_url":"https://www.findmykol.com/institution/university-of-chicago","city":"Chicago","state":"IL","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1851719967","orcid":"0000-0002-4169-5983","openalex":"A5015836506"},"summary":"Mohammad Atiq is an Oncology physician affiliated with University of Chicago. OpenAlex indexes 38 publications with 479 citations (h-index 8).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":38,"cited_by_count":479,"h_index":8,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":6,"program_years":{"first":2021,"last":null},"rows_total":8,"shown":3,"withheld":5,"rows":[{"payer":"Novartis","program_year":2025,"amount_usd":91570.18,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1851719967"},{"payer":"Exelixis Inc.","program_year":2025,"amount_usd":269.36,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1851719967"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":134.98,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1851719967"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1851719967","source":"payments"},"publications":{"total":38,"shown":5,"withheld":33,"matched_by":"OpenAlex author record","recent":[{"title":"High-risk localized prostate cancer treated with neoadjuvant LHRH agonist/antagonist and enzalutamide plus the glucocorticoid receptor antagonist relacorilant versus placebo.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.7_suppl.tps415","status":"verified"},{"title":"Neoadjuvant androgen deprivation therapy with enzalutamide plus the glucocorticoid receptor modulator relacorilant versus placebo for patients with high-risk localized prostate cancer.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.5_suppl.tps436","status":"verified"},{"title":"Emerging treatment options for prostate cancer","year":2023,"journal":"Expert Review of Anticancer Therapy","source_url":"https://doi.org/10.1080/14737140.2023.2208352","status":"verified"},{"title":"First-line pembrolizumab plus androgen deprivation therapy for locally advanced microsatellite instability-high prostate cancer in a patient with Muir-Torre syndrome: A case report","year":2023,"journal":"Frontiers in Oncology","source_url":"https://doi.org/10.3389/fonc.2023.1126476","status":"verified"},{"title":"Effects of docetaxel on circulating immune cell subsets and association with outcomes in metastatic castration-sensitive prostate cancer.","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2023.41.6_suppl.207","status":"verified"}],"source":"works"},"contact":{"address_1":"5841 S MARYLAND AVE","city":"Chicago","state":"IL","zip":"606371443","phone":"773-702-1000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1851719967","source":"identity"},"similar":[{"name":"Everett Vokes","slug":"everett-vokes","institution":"University of Chicago","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/everett-vokes","json_url":"https://www.findmykol.com/kol/everett-vokes/profile.json"},{"name":"Ralph Weichselbaum","slug":"ralph-weichselbaum","institution":"University of Chicago","specialty":"Radiation Oncology","url":"https://www.findmykol.com/kol/ralph-weichselbaum","json_url":"https://www.findmykol.com/kol/ralph-weichselbaum/profile.json"},{"name":"Mary Rinella","slug":"mary-rinella","institution":"University of Chicago","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/mary-rinella","json_url":"https://www.findmykol.com/kol/mary-rinella/profile.json"},{"name":"Hedy Kindler","slug":"hedy-kindler","institution":"University of Chicago","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/hedy-kindler","json_url":"https://www.findmykol.com/kol/hedy-kindler/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":5,"publications":33}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2026-06-03","provider_certified":"2026-06-03","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}